GSK files for extended use of Relvar Ellipta in asthma
admin 24th July 2017 Uncategorised 0GlaxoSmithKline and Innoviva have applied to market Relvar Ellipta for extended use in patients with asthma who are already adequately controlled on inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA) therapy.
More: GSK files for extended use of Relvar Ellipta in asthma
Source: News